Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P29
Within normal range
vs 2Y Ago
-1.5x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -65.47% |
| 2023 | 33.44% |
| 2022 | 42.41% |
| 2021 | -14.48% |
| 2020 | -101.42% |
| 2019 | -223.19% |
| 2018 | -16.87% |
| 2017 | 0.00% |